| Control group | CAPD group | P | ||
---|---|---|---|---|---|
n |     13 |     50 |  | ||
Age, y | 43.0 | (32.0–52.0) | 37.0 | (35.0–44.3) | 0.189 |
Male/female (n) | 7/6 | Â | 28/22 | Â | 0.193 |
BSA (kg/m2) | 1.71 | (1.52–1.80) | 1.68 | (1.43–1.95) | 0.609 |
Height (cm) | 161.0 | (155.5–167.5) | 164.0 | (153.0–168.3) | 0.474 |
Weight (kg) | 62.0 | (52.0–72.3) | 64.0 | (47.5–79.0) | 0.878 |
NT-proBNP (pg/mL) | 4.99 | (4.99–36.83) | 3872 | (808–11779) | <0.001 |
Log NT-proBNP | 0.698 | (0.698–1.540) | 3.587 | (2.896–4.071) | <0.001 |
SDI at baseline (%) | 1.22 | (0.72–1.68) | 1.30 | (0.89–1.74) | 0.358 |
SDI at peak DSE (%) | 0.66 | (0.50–1.02) | 1.11 | (0.76–1.64) | 0.004 |
SWS (mmHg) | 40.5 | (29.6–48.6) | 61.7 | (43.11–100.0) | 0.001 |